Related Experiment Video
Updated: Jun 10, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Experimental models of vascular dementia and vascular cognitive impairment: a systematic review
Nadim S Jiwa1, Peter Garrard, Atticus H Hainsworth
1Clinical Neuroscience, Division of Clinical Sciences, St George's University of London, London, UK.
Insights
Experimental models of vascular cognitive impairment (VCI) show memory deficits and brain lesions similar to human patients. This analysis links animal models to clinical VCI, aiding research into dementia causes.
Area of Science:
- Neuroscience
- Neuropathology
- Experimental Medicine
Background:
- Vascular cognitive impairment (VCI) is the second leading cause of dementia after Alzheimer's disease.
- Key causes include cerebral small vessel disease, multi-infarct dementia, and hereditary vasculopathies like CADASIL.
- Understanding VCI requires correlating experimental findings with clinical manifestations.
Purpose of the Study:
- To systematically analyze and relate cognitive and neuropathological features of experimental VCI models to human clinical VCI.
- To provide a comprehensive overview of current animal models used in VCI research.
Main Methods:
- A systematic analysis of 107 studies involving 16 distinct experimental models of VCI.
- Data extraction focused on cognitive deficits and observed neuropathological lesions.
- Models included global ischemia, chronic hypoperfusion, hypertension, embolic stroke, strategic infarcts, and genetic vasculopathies.
Main Results:
- Most models exhibited deficits in working and reference memory.
- Commonly observed lesions included microinfarcts, white matter lesions, hippocampal neuronal death, focal infarcts, and micro-hemorrhages.
- Bilateral carotid artery occlusion in rats was the most frequently used model, inducing chronic hypoperfusion and white matter injury.
Conclusions:
- Experimental models effectively recapitulate key cognitive and neuropathological aspects of human VCI.
- These models are valuable tools for investigating the mechanisms underlying VCI and for developing therapeutic strategies.
- Further refinement of models can enhance their translatability to clinical VCI.
Abstract:
Vascular cognitive impairment (VCI) encompasses vascular dementia and is the second most common cause of dementing illness after Alzheimer's disease. The main causes of VCI are: cerebral small vessel disease; multi-infarct dementia; strategic infarct (i.e. located in a functionally-critical brain area); haemorrhage/microbleed; angiopathy (including cerebral amyloid angiopathy); severe hypoperfusion (e.g. cardiac arrhythmia); and hereditary vasculopathy (e.g. cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, CADASIL). In this systematic analysis, we aimed to relate cognitive and neuropathological features of experimental models to clinical VCI. We extracted data from 107 studies covering 16 models. These included: brief global ischaemic insults (in rats, mice or gerbils); chronic global hypoperfusion (rats, mice, gerbils); chronic hypertension (in primates or stroke-prone, spontaneously-hypertensive rats); multiple ischaemic lesions because of intra-vascular emboli (in rodents, rabbits or primates); strategic ischaemic lesions (in rats or mini-pigs); generalised vasculopathies, because of mutant Notch3, hyperhomocysteinaemia, experimental diabetes mellitus or lack of cerebral vasodilator M(5) receptors (rats or mice). Most cognitive testing showed deficits in working and reference memory. The lesions observed were microinfarcts, diffuse white matter lesions, hippocampal neuronal death, focal ischaemic lesions and micro-haemorrhages. The most-used model was bilateral carotid artery occlusion in rats, leading to chronic hypoperfusion and white matter injury.
Related Concept Videos
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
